Syra Health Price to Sales Ratio 2022-2024 | SYRA
Historical PS ratio values for Syra Health (SYRA) over the last 10 years. The current P/S ratio for Syra Health as of May 09, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Syra Health P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-08 | 0.10 | 0.08 | |
| 2024-12-31 | 0.41 | $1.14 | 0.36 |
| 2024-09-30 | 0.42 | $1.24 | 0.34 |
| 2024-06-30 | 1.37 | $1.29 | 1.06 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.001B | $0.008B |
| Syra Health Corp. is a healthcare technology company. It offers products and services in digital health, behavioral and mental health, population health management, health education and healthcare workforce. Syra Health Corp. is based in CARMEL, Ind. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.567B | 53.27 |
| Hims & Hers Health (HIMS) | United States | $11.630B | 120.84 |
| Tempus AI (TEM) | United States | $10.569B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.461B | 69.70 |
| IRhythm Technologies (IRTC) | United States | $4.396B | 0.00 |
| Privia Health (PRVA) | United States | $3.050B | 208.50 |
| Enovis (ENOV) | United States | $1.888B | 10.52 |
| Clover Health Investments (CLOV) | United States | $1.793B | 0.00 |
| Schrodinger (SDGR) | United States | $1.746B | 0.00 |
| Phreesia (PHR) | United States | $1.506B | 0.00 |
| Azenta (AZTA) | United States | $1.223B | 56.96 |
| Omnicell (OMCL) | United States | $1.208B | 21.31 |
| 10x Genomics (TXG) | United States | $1.073B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.600B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.509B | 151.00 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.406B | 0.00 |
| TruBridge (TBRG) | United States | $0.371B | 827.00 |
| Claritev (CTEV) | United States | $0.351B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.290B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.195B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
| Pulmonx (LUNG) | United States | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.107B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.089B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.088B | 0.00 |
| CareCloud (CCLD) | United States | $0.081B | 3.07 |
| 111 (YI) | China | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |